Five respiratory viruses. One TaqPath panel.
 

Expand your molecular testing menu to include viral targets with high clinical relevance.

The Applied Biosystems TaqPath Respiratory Viral Select Panel is a multiplex, real-time PCR (qPCR) in vitro diagnostic (IVD) test for identifying five common respiratory viruses in under three hours. The CE-IVD panel includes targets for adenovirus, human metapneumovirus, rhinovirus/enterovirus,* and parainfluenza** virus. Pair this panel with the Applied Biosystems TaqPath COVID-19, Flu A/B, RSV Combo Kit to expand your respiratory virus testing menu.

* Rhinovirus/enterovirus are undifferentiated.
** Coverage of parainfluenza virus includes subtypes 1, 2, 3, and 4; undifferentiated.

Free webinar: Prepare Your Lab for Flu Season with Multiplex PCR

Learn the importance of testing for common respiratory viruses and how two CE-IVD solutions from Thermo Fisher Scientific can help you get ready for flu season.

 

Shared symptoms, different viruses

Whether we are experiencing a seasonal surge or a global pandemic, early and accurate diagnosis of respiratory infections can save lives. As more viral pathogens enter the ecosystem, multiplex testing helps provide the accuracy needed to test for multiple viruses with overlapping infection symptoms.

As demand for reliable respiratory testing solutions continues to grow, we can help you catch up to surges in testing. Our robust multiplex assays, combined with high-quality PCR systems, are designed to enable the detection of five respiratory viruses using the same patient sample. 


Benefits of molecular testing

Offering high sensitivity and fast time-to-results, this powerful PCR panel makes it easy and affordable for you to adopt and add targets to your respiratory testing menu. As the technological migration from rapid to molecular testing continues, the need for expanded molecular testing remains beneficial for at-risk populations, including children, older adults, and people with weakened immune systems. These populations are often at higher risk of severe disease and hospitalization, and need clear answers. PCR testing is designed to deliver accurate results and aid in differential diagnosis, including coinfections, to assist with treatment or other patient management decisions.

Learn more by reading the article, The rise of qPCR testing in clinical diagnostics. Read now ›


Select Taqpath panels

Step-by-Step-OR-Workflow

Validated workflow

Its full workflow, from sample preparation to software-generated result in just 3 hours, makes it easy to implement 

Eppendorf-Tube

Single tube

Detecting 5 viruses and an endogenous internal control, all in a single well, makes it easy to perform routine patient testing

Currency-Euro

Affordable price

Easily adopt this panel, and never overpay for the targets you need

QuantStudio-1-3-5

PCR performance

High sensitivity for the vast majority of strains gives you confidence in results

Infectious-Negative-Control

Controls included

Included RNase P and positive controls offer reliable runs, time after time 

Throughput-Options

Flexible throughput

Scalable to fit your needs, allowing you to test from 1 to 94 samples, as needed


Choose Thermo Fisher Scientific
 

In a time when getting answers quickly is critical, Thermo Fisher Scientific—a global leader in COVID-19 testing—is leveraging its scale and resources to help the world move forward. With innovative solutions and a reliable supply chain already helping to meet the unprecedented demand for trusted COVID-19 testing, we are continuing to expand our high-quality solutions and urgently accelerate innovation to address current and future challenges.

Trusted technology

Our workflow includes an automated purification system for nucleic acid extraction and the Applied Biosystems QuantStudio 5 or 5 Dx real-time PCR systems.

Service and support

Rely on one company for service and support of all steps of the validated workflow. Our experts will help you get up and running and maintain your growing molecular menu.

Growing menu

Our expanding portfolio of Applied Biosystems CE-IVD panels allows you to get more from your existing equipment, like the new Applied Biosystems TaqPath Enteric Bacterial Select Panel.

Hands painted with the global map
Access pricing available to eligible customers. Contact us to learn more.

Learn more



Expand your molecular testing menu with the TaqPath Respiratory Viral Select Panel
 

Product details

Targets

  • Adenovirus
  • Parainfluenza subtypes 1, 2, 3, and 4 (undifferentiated)
  • Rhinovirus and enterovirus (undifferentiated)
  • Human metapneumovirus

Internal control

RNase P

Positive control

Included

Authorized sample types

Nasopharyngeal (NP) swab

Sample prep

MagMAX Viral/Pathogen II Nucleic Acid Isolation Mix

Authorized kit

TaqPath Respiratory Viral Select Panel

Authorized real-time PCR systems

  • QuantStudio 5 (96-well, 0.2 mL)
  • QuantStudio 5 DX

Sample-to-result turnaround time

~3 hours

Software

Pathogen Interpretive Software CE-IVD Edition

Approval

CE-IVD

TaqPath Respiratory Viral Select Panel

Add to your diagnostic testing capabilities using the PCR experience you already have. The fully validated TaqPath Respiratory Viral Select Panel detects common respiratory viruses that share overlapping symptoms, including adenovirus, human metapneumovirus, rhinovirus/enterovirus, and parainfluenza virus.

The TaqPath Respiratory Viral Select Panel assay has been validated for use with nasopharyngeal (NP) swabs obtained from individuals exhibiting symptoms of a respiratory tract infection.

 

Featured resources

 

TaqPath RVSelect flyer image

Five respiratory viruses. One TaqPath panel.

The new, fully validated TaqPath Respiratory Viral Select Panel is a multiplex, real-time PCR (qPCR) in vitro diagnostic (IVD) test for identifying five common respiratory viruses in under three hours.

Download flyer

Illustration of virus releasing viral particles

Blog: The need to expand your molecular respiratory testing

While COVID-19 testing is a top priority for many countries around the world, it is a good time to use those lessons learned and apply them to the viruses causing the common cold.

Read blog

Eppendorf tubes being placed on a metal tray

Article: The rise of qPCR testing in clinical diagnostics

On this sponsored piece, we hear what industry experts believe is the future of molecular testing after lessons of the COVID-19 pandemic.

View article


Analysis and reporting
 

The Applied Biosystems Pathogen Interpretive Software (CE-IVD) is part of the required workflow and must be downloaded prior to instrumentation use. You may download the software upon kit purchase. Labs following the authorized workflow are required to complete an eLearning course and pass an exam to download.

Follow the instructions below to obtain the software from your local support team:

  • Go to thermofisher.com/contactus
  • Select “Instrument Service” as category
  • Enter product name or Cat. No. and select your country
  • Call the local number displayed on the screen
PIS Ce-IVD edition

Interested in this product?

Request more information



Looking for other clinically relevant viral targets?
 

Illustration of three different viruses

Solution for COVID-19, Flu A/B, and RSV

Because RSV, influenza, and COVID-19 share symptoms, accurate testing is needed to distinguish one from the other. This CE-IVD marked multiplex PCR test is specifically designed to detect and differentiate between multiple respiratory viruses as the ongoing COVID-19 pandemic overlaps with respiratory virus season.

Learn more ›


Ordering information
 

Catalog #NameSizePrice (GBP)Qty
A54713TaqPath ™ Respiratory Viral Select Panel200 reactionsOrder now-

 

For In Vitro Diagnostic Use. © 2023 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.

Style Sheet for Global Design System